Study of a New Formulation of DTPa-HBV-IPV/Hib Vaccine Administered as a Booster Dose to 18-23 Months Old Children

Clinical trial NCT00611559 · COMPLETED

Trial details

NCT number: NCT00611559
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Poliomyelitis Acellular Pertussis Tetanus Diphtheria Hepatitis B

Start date: 2008-02-14
Primary completion: 2008-06-25
Enrollment: 283

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.